Name: Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts (Video) | JoVE Journal
Uploaded: 2020-01-22T14:00:00.000+00:00
Duration: 5 min 56 s
Description: Learn to correlate VEGF and LH in kidney cortex extracts using ELISA and linear regression. This method advances renal physiology research in bovine and porcine models.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors thank Scholl&#39;s Slaughterhouse (Blissfield, MI) for providing the bovine and porcine kidneys. No grant funding was utilized for this study.

No live or experimental animals were used for this study.
1. Tissue Handling
<ol>
	<li>Procure bovine and porcine whole kidneys immediately after slaughter from an abattoir. Transport on ice to the laboratory.</li>
	<li>Upon arrival at laboratory, rinse kidneys with 50 mL of ice-cold phosphate buffered saline (PBS). Repeat this step 2x to remove blood completely.</li>
	<li>Keep kidneys on ice (or refrigerated) until further extraction.</li>
</ol>
2. Dissection of Kidneys
<ol>
	<li>Use sterile scissors, forceps, a knife, and Petri dishes to dissect the kidneys and excise the required tissue portion.</li>
	<li>Prepare RIPA lysis buffer prior to kidney dissection. Dissolve 5 mM NaCl, 0.5 M EDTA, 1 M Tris (pH = 8.0), NP-40 (ID + GEPAL CA-630), 10% sodium deoxycholate, and 10% SDS in double-distilled water, then mix thoroughly. Refrigerate the RIPA lysis buffer when not in use.</li>
	<li>Gently cut the kidney in half (sagittal plane) and cut a piece of tissue (50-70 mm2) from the cortex region in the center of the kidney (weighing 80-100 mg by wet weight).</li>
	<li>Mince the tissue block into small pieces with a knife to assist the homogenization process.</li>
	<li>After mincing the tissues, transfer them into a microfuge tube with 1 mL of ice-cold 1x RIPA lysis extraction buffer. Place the tubes in ice until further extraction.</li>
</ol>
3. Tissue Homogenization
<ol>
	<li>Label the microfuge tubes with specific sample details for tissue supernatant collection.</li>
	<li>Using a handheld homogenizer with a sterile probe, then homogenize the tissues for 1-2 min in cold conditions (samples on ice bucket) until no chunks of tissues are visible.</li>
	<li>Subject the tissue extracts immediately for centrifugation in the refrigerated centrifuge at 9,600 x g for 5 min at 4 &#176;C.</li>
	<li>Remove the tubes from the centrifuge and place them on the ice bucket.</li>
	<li>Collect the supernatant into a new labeled microfuge tube and store on ice. Discard the pellet.</li>
	<li>Prepare separate aliquots of the supernatants for LH and VEGF-A enzyme-linked immunosorbent assays (ELISA) and total protein analysis, respectively, to avoid freeze-thaw cycles.</li>
</ol>
4. Bovine and Porcine LH ELISA Assay
<ol>
	<li>Store all ELISA assay components included in the commercially available luteinizing hormone (LH) ELISA kit (see Table of Materials) at 2-8 &#176;C. This includes the antibody, HRP-conjugate, assay plate (96 well), calibrators, wash buffer (20x concentrate), substrate A, substrate B, and stop solution. Prepare all reagents as recommended by the manufacturer&#39;s instructions.</li>
	<li>Before starting the assay, bring all reagents and assay plate to room temperature (RT). Use the required number of wells for the assay, seal, and keep the unused wells at 4 &#176;C until use.</li>
	<li>Dilute the wash buffer (15 mL of 20x concentrate) to 300 mL with double-distilled water</li>
	<li>Set up the blank wells without any solution.</li>
	<li>Add 50 &#181;L of standard or sample to each well (n = 2), then add another 50 &#181;L of horseradish peroxidase (hrp)-conjugate to each well. Immediately add another 50 &#181;L of antibody solution to each well. Seal the plate, mix well, and incubate for 1 h at 37 &#176;C.</li>
	<li>Wash the wells with 1x wash buffer (200 &#181;L/well) and repeat 4x.</li>
	<li>Add 50 &#181;L of substrate A and 50 &#181;L of substrate B to each well, and mix well by tapping the plate on the side gently. Seal the plate and incubate for 15 min at 37 &#176;C in the dark for 15 min.</li>
	<li>Add 50 &#181;L of stop solution to each well, gently tap the plate, and read the plate using the spectrophotometer set to a 450 nm wavelength.</li>
	<li>Normalize bovine and porcine LH levels to total protein (see section 6).</li>
</ol>
5. Bovine and Porcine VEGF-A ELISA Assay
<ol>
	<li>Store all ELISA assay components included in the commercially available Vascular Endothelial Growth Factor-A ELISA kits (see Table of Materials) at 2-8 &#176;C. This includes the antibody, HRP-conjugate, assay plate (96 well), calibrators, wash buffer (20x concentrate), substrate A, substrate B, and stop solution. Prepare all the reagents as recommended by the manufacturer&#39;s instructions.</li>
	<li>Before starting the assay, bring all reagents and assay plate to RT. Use the required number of wells for the assay, seal, and keep the unused wells at 4 &#176;C until use.</li>
	<li>Dilute the wash buffer (15 mL of 20x concentrate) to 300 mL with double-distilled water</li>
	<li>Add 100 &#181;L of the standard or sample to each well (n = 2). Seal the plate, mix well, and incubate for 2 h at 37 &#176;C.</li>
	<li>Remove the liquid in each well and add 100 &#181;L of detection reagent A to each well, seal the plate, and incubate for 1 h at 37 &#176;C.</li>
	<li>Wash the wells with 1x wash buffer (400 &#181;L/well) and repeat 4x.</li>
	<li>Add 100 &#181;L of detection reagent B to each well and mix well by tapping the plate on the side gently. Seal the plate and incubate the plate for 1 h at 37 &#176;C.</li>
	<li>Wash the wells with 1x wash buffer (400 &#181;L/well) and repeat 4x.</li>
	<li>Add 90 &#181;L of substrate solution to each well, gently tap the plate, and incubate for 1 h at 37 &#176;C.</li>
	<li>Add 50 &#181;L of stop solution to each well, gently tap the plate, and read the plate using the spectrophotometer set to a 450 nm wavelength.</li>
	<li>Normalize bovine and porcine VEGF-A levels to total protein (section 6).</li>
</ol>
6. Total Protein Estimation
<ol>
	<li>Estimate total protein of the bovine and porcine kidney extracts by standard bovine serum albumin (BSA) assay using a commercial kit (see Table of Materials) according to the manufacturer&#39;s recommendations.</li>
</ol>
7. Statistical Analysis
<ol>
	<li>Calculate the mean, median, and standard deviation of each analyte.</li>
	<li>Test the divergence of sample distribution from normal utilizing Kolmogorov-Smirnov Test to decide, upon use, between parametric vs. non-parametric statistical tests. If data is normally distributed, then perform statistical testing via parametric tests.</li>
	<li>Under appropriate circumstances (such as normal data distribution), utilize regression models to examine the linear relationship between LH and VEGF-A.</li>
</ol>

<ol><li>Advani, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+of+VEGF+in+maintaining+renal+structure+and+function+under+normotensive+and+hypertensive+conditions%5BTitle%5D)+AND+%22Proceedings+of+the+National+Academy+of+Science+U.+S.+A%22%5BJournal%5D)">Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions.</a> Proceedings of the National Academy of Science U. S. A. 104 (36), 14448-14453 (2007).</li>
<li>Majumder, S., Advani, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((VEGF+and+the+diabetic+kidney%3A+More+than+too+much+of+a+good+thing%5BTitle%5D)+AND+%22Journal+of+Diabetes+and+its+Complications%22%5BJournal%5D)">VEGF and the diabetic kidney: More than too much of a good thing.</a> Journal of Diabetes and its Complications. 31 (1), 273-279 (2017).</li>
<li>Liu, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Increased+expression+of+vascular+endothelial+growth+factor+in+kidney+leads+to+progressive+impairment+of+glomerular+functions%5BTitle%5D)+AND+%22Journal+of+the+American+Society+of+Nephrology%22%5BJournal%5D)">Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.</a> Journal of the American Society of Nephrology. 18 (7), 2094-2104 (2007).</li>
<li>Eremina, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Glomerular-specific+alterations+of+VEGF-A+expression+lead+to+distinct+congenital+and+acquired+renal+diseases%5BTitle%5D)+AND+%22Journal+of+Clinical+Investigation%22%5BJournal%5D)">Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.</a> Journal of Clinical Investigation. 111 (5), 707-716 (2003).</li>
<li>Ferrara, N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vascular+endothelial+growth+factor%3A+basic+science+and+clinical+progress%5BTitle%5D)+AND+%22Endocrine+Reviews%22%5BJournal%5D)">Vascular endothelial growth factor: basic science and clinical progress.</a> Endocrine Reviews. 25 (4), 581-611 (2004).</li>
<li>Movsas, T. Z., Sigler, R., Muthusamy, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Vitreous+Levels+of+Luteinizing+Hormone+and+VEGF+are+Strongly+Correlated+in+Healthy+Mammalian+Eyes%5BTitle%5D)+AND+%22Current+Eye+Research%22%5BJournal%5D)">Vitreous Levels of Luteinizing Hormone and VEGF are Strongly Correlated in Healthy Mammalian Eyes.</a> Current Eye Research. 43 (8), 1041-1044 (2018).</li>
<li>Babitha, V., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Luteinizing+hormone%2C+insulin+like+growth+factor-1%2C+and+epidermal+growth+factor+stimulate+vascular+endothelial+growth+factor+production+in+cultured+bubaline+granulosa+cells%5BTitle%5D)+AND+%22General+and+Comparative+Endocrinology%22%5BJournal%5D)">Luteinizing hormone, insulin like growth factor-1, and epidermal growth factor stimulate vascular endothelial growth factor production in cultured bubaline granulosa cells.</a> General and Comparative Endocrinology. 198, 1-12 (2014).</li>
<li>Trau, H. A., Davis, J. S., Duffy, D. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Angiogenesis+in+the+Primate+Ovulatory+Follicle+Is+Stimulated+by+Luteinizing+Hormone+via+Prostaglandin+E2%5BTitle%5D)+AND+%22Biology+of+Reproduction%22%5BJournal%5D)">Angiogenesis in the Primate Ovulatory Follicle Is Stimulated by Luteinizing Hormone via Prostaglandin E2.</a> Biology of Reproduction. 92 (1), 15(2015).</li>
<li>Movsas, T. Z., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Confirmation+of+Luteinizing+Hormone+%28LH%29+in+Living+Human+Vitreous+and+the+Effect+of+LH+Receptor+Reduction+on+Murine+Electroretinogram%5BTitle%5D)+AND+%22Neuroscience%22%5BJournal%5D)">Confirmation of Luteinizing Hormone (LH) in Living Human Vitreous and the Effect of LH Receptor Reduction on Murine Electroretinogram.</a> Neuroscience. 385, 1-10 (2018).</li>
<li>Movsas, T. Z., Sigler, R., Muthusamy, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Elimination+of+Signaling+by+the+Luteinizing+Hormone+Receptor+Reduces+Ocular+VEGF+and+Retinal+Vascularization+during+Mouse+Eye+Development%5BTitle%5D)+AND+%22Current+Eye+Research%22%5BJournal%5D)">Elimination of Signaling by the Luteinizing Hormone Receptor Reduces Ocular VEGF and Retinal Vascularization during Mouse Eye Development.</a> Current Eye Research. 43 (10), 1286-1289 (2018).</li>
<li>Hipkin, R. W., Sanchez-Yague, J., Ascoli, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Identification+and+characterization+of+a+luteinizing+hormone%2Fchorionic+gonadotropin+%28LH%2FCG%29+receptor+precursor+in+a+human+kidney+cell+line+stably+transfected+with+the+rat+luteal+LH%2FCG+receptor+complementary+DNA%5BTitle%5D)+AND+%22Molecular+Endocrinology%22%5BJournal%5D)">Identification and characterization of a luteinizing hormone/chorionic gonadotropin (LH/CG) receptor precursor in a human kidney cell line stably transfected with the rat luteal LH/CG receptor complementary DNA.</a> Molecular Endocrinology. 6 (12), 2210-2218 (1992).</li>
<li>Lei, Z. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Targeted+disruption+of+luteinizing+hormone%2Fhuman+chorionic+gonadotropin+receptor+gene%5BTitle%5D)+AND+%22Molecular+Endocrinology%22%5BJournal%5D)">Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene.</a> Molecular Endocrinology. 15 (1), 184-200 (2001).</li>
<li>Schrijvers, B. F., Flyvbjerg, A., De Vriese, A. S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+role+of+vascular+endothelial+growth+factor+%28VEGF%29+in+renal+pathophysiology%5BTitle%5D)+AND+%22Kidney+International%22%5BJournal%5D)">The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.</a> Kidney International. 65 (6), 2003-2017 (2004).</li>
<li>Apaja, P. M., Aatsinki, J. T., Rajaniemim, H. J., Petaja-Repo, U. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Expression+of+the+mature+luteinizing+hormone+receptor+in+rodent+urogenital+and+adrenal+tissues+is+developmentally+regulated+at+a+posttranslational+level%5BTitle%5D)+AND+%22Endocrinology%22%5BJournal%5D)">Expression of the mature luteinizing hormone receptor in rodent urogenital and adrenal tissues is developmentally regulated at a posttranslational level.</a> Endocrinology. 146 (8), 3224-3232 (2005).</li>
<li>Ondruschka, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Post-mortem+in+situ+stability+of+serum+markers+of+cerebral+damage+and+acute+phase+response%5BTitle%5D)+AND+%22International+Journal+of+Legal+Medicine%22%5BJournal%5D)">Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.</a> International Journal of Legal Medicine. 133 (3), 871-881 (2019).</li>
<li>Swain, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Estimation+of+post-mortem+interval%3A+A+comparison+between+cerebrospinal+fluid+and+vitreous+humour+chemistry%5BTitle%5D)+AND+%22Journal+of+Forensic+and+Legal+Medicine%22%5BJournal%5D)">Estimation of post-mortem interval: A comparison between cerebrospinal fluid and vitreous humour chemistry.</a> Journal of Forensic and Legal Medicine. 36, 144-148 (2015).</li>
<li>Thompson, C. S., Traynor, I. M., Fodey, T. L., Faulkner, D. V., Crooks, S. R. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Screening+method+for+the+detection+of+residues+of+amphenicol+antibiotics+in+bovine%2C+ovine+and+porcine+kidney+by+optical+biosensor%5BTitle%5D)+AND+%22Talanta%22%5BJournal%5D)">Screening method for the detection of residues of amphenicol antibiotics in bovine, ovine and porcine kidney by optical biosensor.</a> Talanta. 172, 120-125 (2017).</li>
<li>Konstantinou, G. N. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Enzyme-Linked+Immunosorbent+Assay+%28ELISA%29%5BTitle%5D)+AND+%22Methods+in+Molecular+Biology%22%5BJournal%5D)">Enzyme-Linked Immunosorbent Assay (ELISA).</a> Methods in Molecular Biology. 1592, 79-94 (2017).</li>
<li>Levesque, B. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Low+urine+vascular+endothelial+growth+factor+levels+are+associated+with+mechanical+ventilation%2C+bronchopulmonary+dysplasia+and+retinopathy+of+prematurity%5BTitle%5D)+AND+%22Neonatology%22%5BJournal%5D)">Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity.</a> Neonatology. 104 (1), 56-64 (2013).</li>
<li>Leviton, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Antecedents+and+early+correlates+of+high+and+low+concentrations+of+angiogenic+proteins+in+extremely+preterm+newborns%5BTitle%5D)+AND+%22Clinica+Chimica+Acta%22%5BJournal%5D)">Antecedents and early correlates of high and low concentrations of angiogenic proteins in extremely preterm newborns.</a> Clinica Chimica Acta. 471, 1-5 (2017).</li>
<li>Simo-Servat, O., Hernandez, C., Simo, R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Usefulness+of+the+vitreous+fluid+analysis+in+the+translational+research+of+diabetic+retinopathy%5BTitle%5D)+AND+%22Mediators+of+Inflammation%22%5BJournal%5D)">Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.</a> Mediators of Inflammation. , 872978(2012).</li>
<li>Sharma, R. K., Rowe-Rendleman, C. L. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Validation+of+molecular+and+genomic+biomarkers+of+retinal+drug+efficacy%3A+use+of+ocular+fluid+sampling+to+evaluate+VEGF%5BTitle%5D)+AND+%22Neurochemical+Research%22%5BJournal%5D)">Validation of molecular and genomic biomarkers of retinal drug efficacy: use of ocular fluid sampling to evaluate VEGF.</a> Neurochemical Research. 36 (4), 655-667 (2011).</li>
</ol>

Zietchick Research Institute (ZRI) is a private (for-profit) research institute, and Dr. Tammy Movsas (founder and director of ZRI) has a pending patent applications and validated patents for the use of gonadotropin antagonists in the treatment of ocular diseases and diabetes. Other than being an employee (biochemist) at ZRI, Dr. A. Muthusamy has no other financial conflicts to report. A. Arivalagan (summer intern at ZRI, undergraduate student at University of Michigan) has no other financial conflicts to report.

Procuring kidneys from the abattoir immediately after animal death is the key to success in this methodology. This is the main advantage of utilizing organs from cows and pigs instead of human cadavers. There is usually at least a 12-24 h delay from the time of death until human cadaver organs are procured. Because the chemical composition of bodily organs significantly changes within 2 h post-mortem15,16, VEGF-studies in human cadaver kidneys may not reflect rea...

Vascular endothelial growth factor A (VEGF-A), helps to regulate angiogenesis and vascular permeability in the kidney and other organs1,2 (hereafter, VEGF-A will be referred to as VEGF). VEGF levels in the kidney are under tight homeostatic control. When renal VEGF levels are elevated or depressed, the kidney can malfunction. For example, within 3 weeks after birth, mice with podocyte-specific heterozygosity for VEGF develop endotheliosis and bloodless glomeruli (i.e, renal lesions seen in human preeclampsia), and end-stage kidney failure occurs in these heterozygotes by 3 months of age. Podocyte-specific homozygotic knockouts die from hydrops and kidney failure within 1 day of birth3,4.
On the other hand, overexpression of renal VEGF causes proteinuria and glomerular hypertrophy3,4. For example, transgenic rabbits that overexpress VEGF exhibit progressive proteinuria with increased glomerular filtration rates in early stages of nephropathy, followed by decreased glomerular filtration rates in later stages3. Diabetic nephropathy, a major cause of end-stage renal disease in diabetic adults, is strongly associated with VEGF dysregulation2,5. A great deal of attention has been paid to the role of hypoxia in inducing VEGF expression under pathologic conditions5. However, the factors governing VEGF under physiologic conditions (both in the kidney and other organs) are not well-understood2,6. Identifying these factors (except for oxygen) that are involved in physiologic and pathologic VEGF regulation is an important undertaking.
Luteinizing hormone (LH), a pro-angiogenic hormone, helps regulate physiologic VEGF expression in reproductive organs such as the ovary and testis7,8. Previous studies have provided evidence that LH also helps regulate VEGF in non-reproductive organs, such as the eyes6,9,10. LH receptors are found in the medulla and cortex of the kidney11,12. Of note, kidney tubular epithelial cells, as well as the LH receptor, express VEGF11,12,13,14. Taking these two observations together, we hypothesized that LH also helps regulate VEGF expression in the kidney13,14. To provide evidence of this LH/VEGF relationship, the presented protocol aims to show that LH levels are able to predict VEGF levels in the kidney. Many previous VEGF-related investigations involving the kidney have used lower order mammal models (i.e., rodents and rabbits)2. To translate this work to the human body, the study examines the relationship between VEGF and LH in higher order mammals (here, bovine and porcine models). To carry out this objective, total protein lysate was prepared from the cortex region of bovine and porcine kidneys.

<table><tbody><tr><td>Bovine LH ELISA Kit</td><td>MyBiosource, San Diego, CA.</td><td>MBS700951</td><td></td></tr><tr><td>Bovine VEGF-A ELISA Kit</td><td>MyBiosource, San Diego, CA.</td><td>MBS2887434</td><td></td></tr><tr><td>Micro BCA Protein Assay Kit</td><td>ThermoFisher Scientific Inc, Columbus, OH.</td><td>23235</td><td></td></tr><tr><td>Porcine LH ELISA Kit</td><td>MyBiosource, San Diego, CA.</td><td>MBS009739</td><td></td></tr><tr><td>Porcine VEGF-A ELISA</td><td>Ray Biotech, Norcross, GA.</td><td>ELP-VEGFA-1</td><td></td></tr><tr><td>RIPA Lysis and Extraction Buffer</td><td>ThermoFisher Scientific Inc, Columbus, OH.</td><td>89901</td><td></td></tr></tbody></table>

demonstrating a linear relationship between vascular endothelial growth factor and luteinizing hormone in kidney cortex extracts

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Vascular endothelial growth factor (VEGF) helps to control angiogenesis and vascular permeability in the kidney. Renal disorders, such as diabetic nephropathy, are associated with VEGF dysregulation in the kidney. The factors that govern VEGF under physiologic conditions in the kidney are not well-understood. Luteinizing hormone (LH), a pro-angiogenic hormone, helps regulate physiologic VEGF expression in reproductive organs. Given that LH receptors are found in the kidney, we, at Zietchick Research Institute, hypothesized here that LH also helps regulate VEGF expression in the kidney as well. To provide evidence, we aimed to show that LH levels are able to predict VEGF levels in the mammalian kidney. Most VEGF-related investigations involving the kidney have used lower order mammals as models (i.e., rodents and rabbits). To translate this work to the human body, it was decided to examine the relationship between VEGF and LH in higher order mammals (i.e., bovine and porcine models). This protocol uses the total protein lysate from the kidney cortex. Keys to this method&#39;s success include procurement of kidneys from slaughterhouse animals immediately after death as well as normalization of analyte levels (in the kidney extract) by total protein. This study successfully demonstrates a significant linear relationship between LH and VEGF in both bovine and porcine kidneys. The results are reproducible in two different species. The study provides supporting evidence that the use of kidney extracts from cows and pigs are an excellent, economical, and abundant resource for the study of renal physiology, particularly for examining the correlation between VEGF and other analytes.

The mean and median levels of LH and VEGF by animal type and by sex are shown in Table 1. After verifying normality of data by Kolmogorov-Smirnov Testing of normality, linear regression models were utilized to examine the relationship between LH and VEGF. LH was found to be a strong and significant predictor of VEGF in both bovine and porcine kidneys (bovine kidney model: n = 7, R2 = 0.86, p = 0.002; porcine kidney model: n = 7; R2 = 0.66, p = 0.025)...

Presented here is a protocol for utilizing a cortical kidney extract preparation and total protein normalization to demonstrate the correlation between vascular endothelial growth factor and luteinizing hormone in the mammalian kidney.

Vascular endothelial growth factor (VEGF) helps to control angiogenesis and vascular permeability in the kidney. Renal disorders, such as diabetic ...

demonstrating-linear-relationship-between-vascular-endothelial-growth

Research

JoVE Journal

Biology

We describe a simple cell-based bioassay for detecting, quantifying and monitoring the activity of members of the vascular endothelial growth factor family of ligands. The assay uses chimeric receptors expressed in a factor-dependent cell line to provide a semi-quantitative or quantitative assessment of receptor binding and cross-linking by the ligand.

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

This manuscript describes a tube formation assay to quantify the effects of a given compound or condition on angiogenesis by using endothelial cell tube formation in a controlled environment.

Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix

The administration of drugs for recovery of kidney function requires control of the localization and distribution of the therapeutic compound. Here, we describe in detail a simple technique for intrarenal delivery of drugs in rats. This procedure may be easily performed with no mortality and high reproducibility.

Intravascular Delivery of Biologics to the Rat Kidney

This protocol describes a full kidney work-up that should be carried out in mouse models of glomerular disease. The methods allow for detailed functional, structural, and mechanistic analysis of glomerular function, which can be applied to all mouse models of glomerular disease.

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Here we present a tail-tip blood sampling protocol for frequent sample collection in unrestrained mice. This method is useful for assessing patterns of pulsatile luteinizing hormone secretion and could be adapted for analysis of other circulating factors.

Frequent Tail-tip Blood Sampling in Mice for the Assessment of Pulsatile Luteinizing Hormone Secretion

Follicle-stimulating hormone (FSH) in various extragonadal tissues and organs is associated with the pathogenesis of multiple diseases. The ovariectomized and FSH-treated mouse model (OVF) can be used to explore the extragonadal actions of FSH.

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Here, we present protocols that detail instructions for implementing 3D cell cultures using collagen and collagen-agarose matrixes in a microphysiological system. These protocols support renal proximal tubule and renal cell carcinoma spheroids co-culture, simulating in vivo conditions and enabling advanced investigation of kidney cancer cell interactions.

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

This video demonstrates two methods for preparing and placing beads, which have been coated with growth factor, on explants of the developing cerebral cortex.   These beads can be used to induce spatially restricted gene expression on developing neural tissue such as forebrain explants.  Methods are given for using both Affi-Gel beads and heparin acryllic beads.

Growth Factor-Coated Bead Placement on Dorsal Forebrain Explants

A variety of growth factors and proteins interact to induce cells to take on different cell fates during development.  Here we demonstrate the use of an in ovo preparation to address possible interactions between different proteins in development by placing beads on E2.5 chick embryos.

Placing Growth Factor-Coated Beads on Early Stage Chicken Embryos

We describe the preparation of T cell growth factor used for the in vitro expansion of antigen-specific rat T lymphocyte lines.

Preparing T Cell Growth Factor from Rat Splenocytes

Learn to correlate VEGF and LH in kidney cortex extracts using ELISA and linear regression. This method advances renal physiology research in bovine and porcine models.

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts (Video) | JoVE Journal

Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts

Explore More Videos